Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Studies Open to Enrollment

Studies Open to Enrollment

Purpose 2 / Lenacapavir Long-acting Investigational PrEP Trial

Hello, Chicagoland!

Project WISH in the Department of Medicine at the University of Illinois Chicago (UIC) is conducting a Phase 3 long-acting investigational PrEP trial. Would you like to volunteer for a 2x/year PrEP injectable trial?

You may qualify. Are you:

  • Currently not on PrEP?
  • 18 years of age or older?
  • Wanting HIV testing, but haven’t done it in 3 months?
  • Bottoming and only sometimes use a condom?
Studies Open to Enrollment
  • Any part of any of the following groups:
    •  Race/Ethnicity
      • American Indian
      • Asian
      • Black
      • Latinx (of any race)
      • Native Hawaiian or Pacific Islander
      • White (if you are transgender/nonbinary or if you identify as Latinx)
      • Mixed ancestry
    • Gender Identity:
      • Cisgender man (of color, Latinx, or of mixed ancestry) who has sex with men
      • Transgender men/women or gender nonbinary individuals (of any race/ethnicity)

For more information about the Gilead lenacapavir investigational trial and how to join, email us at ProjectWISHdom@uic.edu or call us at 312.413.5897. Additionally, you may go to the study website at https://www.purposestudies.com/purpose2/ and/or Clin Trials.gov at https://clinicaltrials.gov/ct2/show/NCT04925752to learn more about the study, look at reasons to consider participation, and check out the clinical research and study FAQ lists.

UIC Principal Investigator(s):

  • Richard M. Novak, MD (he/him)

Study Coordinator:

  • Diana Bahena (she/her)

Community Affairs Specialist:

  • Charlie Peterson (he/him)